Click for best price
Ophthalmic Therapeutics & Drug Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Therapeutics & Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Therapeutics & Drug. This report contains market size and forecasts of Ophthalmic Therapeutics & Drug in global, including the following market information:
Global Ophthalmic Therapeutics & Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Ophthalmic Therapeutics & Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Anti-allergy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Therapeutics & Drug include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc. and Valeant, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ophthalmic Therapeutics & Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Therapeutics & Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Ophthalmic Therapeutics & Drug Market Segment Percentages, by Type, 2022 (%)
- Anti-allergy
- Anti-VEGF Agents
- Anti-inflammatory
- Anti-glaucoma
- Others
Global Ophthalmic Therapeutics & Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Ophthalmic Therapeutics & Drug Market Segment Percentages, by Application, 2022 (%)
- Dry Eye
- Allergies
- Glaucoma
- Infection
- Retinal Disorders
- Uveitis
- Others
Global Ophthalmic Therapeutics & Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Ophthalmic Therapeutics & Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Ophthalmic Therapeutics & Drug revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Ophthalmic Therapeutics & Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Alcon
- Johnson and Johnson Vision Care, Inc.
- Bausch & Lomb Incorporated
- Novartis AG
- Merck Sharp & Dohme Corp.
- Regeneron Pharmaceuticals Inc.
- Allergan
- Pfizer Inc.
- Valeant
- Bayer AG
- Santen Pharmaceuticals Co. Ltd
- Genentech, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Therapeutics & Drug, market overview.
Chapter 2: Global Ophthalmic Therapeutics & Drug market size in revenue.
Chapter 3: Detailed analysis of Ophthalmic Therapeutics & Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Therapeutics & Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ophthalmic Therapeutics & Drug Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Therapeutics & Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Therapeutics & Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Therapeutics & Drug Overall Market Size
2.1 Global Ophthalmic Therapeutics & Drug Market Size: 2022 VS 2030
2.2 Global Ophthalmic Therapeutics & Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ophthalmic Therapeutics & Drug Players in Global Market
3.2 Top Global Ophthalmic Therapeutics & Drug Companies Ranked by Revenue
3.3 Global Ophthalmic Therapeutics & Drug Revenue by Companies
3.4 Top 3 and Top 5 Ophthalmic Therapeutics & Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ophthalmic Therapeutics & Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ophthalmic Therapeutics & Drug Players in Global Market
3.6.1 List of Global Tier 1 Ophthalmic Therapeutics & Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Ophthalmic Therapeutics & Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ophthalmic Therapeutics & Drug Market Size Markets, 2022 & 2030
4.1.2 Anti-allergy
4.1.3 Anti-VEGF Agents
4.1.4 Anti-inflammatory
4.1.5 Anti-glaucoma
4.1.6 Others
4.2 By Type - Global Ophthalmic Therapeutics & Drug Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Therapeutics & Drug Revenue, 2018-2023
4.2.2 By Type - Global Ophthalmic Therapeutics & Drug Revenue, 2024-2030
4.2.3 By Type - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Therapeutics & Drug Market Size, 2022 & 2030
5.1.2 Dry Eye
5.1.3 Allergies
5.1.4 Glaucoma
5.1.5 Infection
5.1.6 Retinal Disorders
5.1.7 Uveitis
5.1.8 Others
5.2 By Application - Global Ophthalmic Therapeutics & Drug Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Therapeutics & Drug Revenue, 2018-2023
5.2.2 By Application - Global Ophthalmic Therapeutics & Drug Revenue, 2024-2030
5.2.3 By Application - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Ophthalmic Therapeutics & Drug Market Size, 2022 & 2030
6.2 By Region - Global Ophthalmic Therapeutics & Drug Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Therapeutics & Drug Revenue, 2018-2023
6.2.2 By Region - Global Ophthalmic Therapeutics & Drug Revenue, 2024-2030
6.2.3 By Region - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Ophthalmic Therapeutics & Drug Revenue, 2018-2030
6.3.2 US Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.3.3 Canada Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.3.4 Mexico Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Ophthalmic Therapeutics & Drug Revenue, 2018-2030
6.4.2 Germany Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.4.3 France Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.4.4 U.K. Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.4.5 Italy Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.4.6 Russia Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.4.7 Nordic Countries Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.4.8 Benelux Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Ophthalmic Therapeutics & Drug Revenue, 2018-2030
6.5.2 China Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.5.3 Japan Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.5.4 South Korea Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.5.5 Southeast Asia Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.5.6 India Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Ophthalmic Therapeutics & Drug Revenue, 2018-2030
6.6.2 Brazil Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.6.3 Argentina Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ophthalmic Therapeutics & Drug Revenue, 2018-2030
6.7.2 Turkey Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.7.3 Israel Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Ophthalmic Therapeutics & Drug Market Size, 2018-2030
6.7.5 UAE Ophthalmic Therapeutics & Drug Market Size, 2018-2030
7 Ophthalmic Therapeutics & Drug Companies Profiles
7.1 Alcon
7.1.1 Alcon Company Summary
7.1.2 Alcon Business Overview
7.1.3 Alcon Ophthalmic Therapeutics & Drug Major Product Offerings
7.1.4 Alcon Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.1.5 Alcon Key News & Latest Developments
7.2 Johnson and Johnson Vision Care, Inc.
7.2.1 Johnson and Johnson Vision Care, Inc. Company Summary
7.2.2 Johnson and Johnson Vision Care, Inc. Business Overview
7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Major Product Offerings
7.2.4 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.2.5 Johnson and Johnson Vision Care, Inc. Key News & Latest Developments
7.3 Bausch & Lomb Incorporated
7.3.1 Bausch & Lomb Incorporated Company Summary
7.3.2 Bausch & Lomb Incorporated Business Overview
7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Major Product Offerings
7.3.4 Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.3.5 Bausch & Lomb Incorporated Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Ophthalmic Therapeutics & Drug Major Product Offerings
7.4.4 Novartis AG Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Merck Sharp & Dohme Corp.
7.5.1 Merck Sharp & Dohme Corp. Company Summary
7.5.2 Merck Sharp & Dohme Corp. Business Overview
7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Major Product Offerings
7.5.4 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.5.5 Merck Sharp & Dohme Corp. Key News & Latest Developments
7.6 Regeneron Pharmaceuticals Inc.
7.6.1 Regeneron Pharmaceuticals Inc. Company Summary
7.6.2 Regeneron Pharmaceuticals Inc. Business Overview
7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Major Product Offerings
7.6.4 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.6.5 Regeneron Pharmaceuticals Inc. Key News & Latest Developments
7.7 Allergan
7.7.1 Allergan Company Summary
7.7.2 Allergan Business Overview
7.7.3 Allergan Ophthalmic Therapeutics & Drug Major Product Offerings
7.7.4 Allergan Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.7.5 Allergan Key News & Latest Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Summary
7.8.2 Pfizer Inc. Business Overview
7.8.3 Pfizer Inc. Ophthalmic Therapeutics & Drug Major Product Offerings
7.8.4 Pfizer Inc. Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.8.5 Pfizer Inc. Key News & Latest Developments
7.9 Valeant
7.9.1 Valeant Company Summary
7.9.2 Valeant Business Overview
7.9.3 Valeant Ophthalmic Therapeutics & Drug Major Product Offerings
7.9.4 Valeant Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.9.5 Valeant Key News & Latest Developments
7.10 Bayer AG
7.10.1 Bayer AG Company Summary
7.10.2 Bayer AG Business Overview
7.10.3 Bayer AG Ophthalmic Therapeutics & Drug Major Product Offerings
7.10.4 Bayer AG Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.10.5 Bayer AG Key News & Latest Developments
7.11 Santen Pharmaceuticals Co. Ltd
7.11.1 Santen Pharmaceuticals Co. Ltd Company Summary
7.11.2 Santen Pharmaceuticals Co. Ltd Business Overview
7.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Major Product Offerings
7.11.4 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.11.5 Santen Pharmaceuticals Co. Ltd Key News & Latest Developments
7.12 Genentech, Inc.
7.12.1 Genentech, Inc. Company Summary
7.12.2 Genentech, Inc. Business Overview
7.12.3 Genentech, Inc. Ophthalmic Therapeutics & Drug Major Product Offerings
7.12.4 Genentech, Inc. Ophthalmic Therapeutics & Drug Revenue in Global Market (2018-2023)
7.12.5 Genentech, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ophthalmic Therapeutics & Drug Market Opportunities & Trends in Global Market
Table 2. Ophthalmic Therapeutics & Drug Market Drivers in Global Market
Table 3. Ophthalmic Therapeutics & Drug Market Restraints in Global Market
Table 4. Key Players of Ophthalmic Therapeutics & Drug in Global Market
Table 5. Top Ophthalmic Therapeutics & Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ophthalmic Therapeutics & Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ophthalmic Therapeutics & Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ophthalmic Therapeutics & Drug Product Type
Table 9. List of Global Tier 1 Ophthalmic Therapeutics & Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Therapeutics & Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Ophthalmic Therapeutics & Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ophthalmic Therapeutics & Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Ophthalmic Therapeutics & Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ophthalmic Therapeutics & Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Ophthalmic Therapeutics & Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ophthalmic Therapeutics & Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2024-2030
Table 30. Alcon Company Summary
Table 31. Alcon Ophthalmic Therapeutics & Drug Product Offerings
Table 32. Alcon Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Alcon Key News & Latest Developments
Table 34. Johnson and Johnson Vision Care, Inc. Company Summary
Table 35. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Product Offerings
Table 36. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson and Johnson Vision Care, Inc. Key News & Latest Developments
Table 38. Bausch & Lomb Incorporated Company Summary
Table 39. Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Product Offerings
Table 40. Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bausch & Lomb Incorporated Key News & Latest Developments
Table 42. Novartis AG Company Summary
Table 43. Novartis AG Ophthalmic Therapeutics & Drug Product Offerings
Table 44. Novartis AG Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis AG Key News & Latest Developments
Table 46. Merck Sharp & Dohme Corp. Company Summary
Table 47. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Product Offerings
Table 48. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Merck Sharp & Dohme Corp. Key News & Latest Developments
Table 50. Regeneron Pharmaceuticals Inc. Company Summary
Table 51. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Product Offerings
Table 52. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Regeneron Pharmaceuticals Inc. Key News & Latest Developments
Table 54. Allergan Company Summary
Table 55. Allergan Ophthalmic Therapeutics & Drug Product Offerings
Table 56. Allergan Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Allergan Key News & Latest Developments
Table 58. Pfizer Inc. Company Summary
Table 59. Pfizer Inc. Ophthalmic Therapeutics & Drug Product Offerings
Table 60. Pfizer Inc. Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Inc. Key News & Latest Developments
Table 62. Valeant Company Summary
Table 63. Valeant Ophthalmic Therapeutics & Drug Product Offerings
Table 64. Valeant Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Valeant Key News & Latest Developments
Table 66. Bayer AG Company Summary
Table 67. Bayer AG Ophthalmic Therapeutics & Drug Product Offerings
Table 68. Bayer AG Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer AG Key News & Latest Developments
Table 70. Santen Pharmaceuticals Co. Ltd Company Summary
Table 71. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Product Offerings
Table 72. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Santen Pharmaceuticals Co. Ltd Key News & Latest Developments
Table 74. Genentech, Inc. Company Summary
Table 75. Genentech, Inc. Ophthalmic Therapeutics & Drug Product Offerings
Table 76. Genentech, Inc. Ophthalmic Therapeutics & Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Genentech, Inc. Key News & Latest Developments
List of Figures
Figure 1. Ophthalmic Therapeutics & Drug Segment by Type in 2022
Figure 2. Ophthalmic Therapeutics & Drug Segment by Application in 2022
Figure 3. Global Ophthalmic Therapeutics & Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Therapeutics & Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ophthalmic Therapeutics & Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ophthalmic Therapeutics & Drug Revenue in 2022
Figure 8. By Type - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 16. US Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 20. Germany Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 28. China Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Ophthalmic Therapeutics & Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Ophthalmic Therapeutics & Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Alcon Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis AG Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Allergan Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Inc. Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Valeant Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer AG Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Genentech, Inc. Ophthalmic Therapeutics & Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
